Picture of THC Biomed Intl logo

THC THC Biomed Intl Cashflow Statement

0.000.00%
ca flag iconLast trade - 00:00
HealthcareSpeculativeMicro Cap

Annual cashflow statement for THC Biomed Intl, fiscal year end - July 31st, CAD millions except per share, conversion factor applied.

2018
July 31st
2019
July 31st
2020
July 31st
2021
July 31st
2022
July 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-12.5-12.7-0.162-6.36-3.07
Depreciation
Non-Cash Items10.710.2-1.413.620.74
Unusual Items
Other Non-Cash Items
Changes in Working Capital-0.8260.0020.6750.75-0.46
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Payable / Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Cash from Operating Activities-2.43-1.870.115-1.01-1.86
Capital Expenditures-5.13-7.16-1.43-0.369-0.16
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items0.0710.007-0.083-0.0282.64
Sale of Fixed Assets
Other Investing Cash Flow
Cash from Investing Activities-5.06-7.15-1.51-0.3972.48
Financing Cash Flow Items-0.450.475-0.08100.029
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities9.4881.160.767-0.25
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash1.98-1.02-0.24-0.640.373